Merck discloses probe of possible violations of anti-bribery laws 8/9/2010
Two federal agencies are probing drugmaker Merck (MRK) for possibly violating anti-bribery laws in multiple foreign countries.
Merck, the world’s second-biggest drugmaker by revenue, has received inquiry letters from both the Department of Justice and the Securities and Exchange Commission, the company said in a regulatory filing.
The letters “seek information about activities in a number of countries and reference the Foreign Corrupt Practices Act,” according to Merck.
The act bars U.S. companies from bribing government or corporate officials in other countries to win business, among other things.
usatoday.com/money/industries/health/drugs/2010-08-09-merck-probe-foreign-sales-practices_N.htm